Advertisement

Index by author

April 01, 1993; Volume 43,Issue 4

A

  1. Allegra, C J

    1. Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-gamma.
      E Chu, D M Koeller, P G Johnston, S Zinn and C J Allegra
      Molecular Pharmacology April 1993, 43 (4) 527-533;

  2. Ammer, H

    1. Coupling of prostaglandin E1 receptors to the stimulatory GTP-binding protein Gs is enhanced in neuroblastoma x glioma (NG108-15) hybrid cells chronically exposed to an opioid.
      H Ammer and R Schulz
      Molecular Pharmacology April 1993, 43 (4) 556-563;

  3. Anné, J

    1. Kinetics of different human immunodeficiency virus type 1 reverse transcriptases resistant to human immunodeficiency virus type 1-specific reverse transcriptase inhibitors.
      Z Debyser, K De Vreese, P P Knops-Gerrits, V Baekelandt, R Bhikhabhai, B Strandberg, R Pauwels, J Anné, J Desmyter and E De Clercq
      Molecular Pharmacology April 1993, 43 (4) 521-526;

  4. Armstrong, S G

    1. Mechanism of hepatic cytochrome P450 modulation during Listeria monocytogenes infection in mice.
      S G Armstrong and K W Renton
      Molecular Pharmacology April 1993, 43 (4) 542-547;

  5. Ashburn, S P

    1. Microsomal hydroxylation of 2- and 4-fluoroestradiol to catechol metabolites and their conversion to methyl ethers: catechol estrogens as possible mediators of hormonal carcinogenesis.
      S P Ashburn, X Han and J G Liehr
      Molecular Pharmacology April 1993, 43 (4) 534-541;

B

  1. Baekelandt, V

    1. Kinetics of different human immunodeficiency virus type 1 reverse transcriptases resistant to human immunodeficiency virus type 1-specific reverse transcriptase inhibitors.
      Z Debyser, K De Vreese, P P Knops-Gerrits, V Baekelandt, R Bhikhabhai, B Strandberg, R Pauwels, J Anné, J Desmyter and E De Clercq
      Molecular Pharmacology April 1993, 43 (4) 521-526;

  2. Bhat, R

    1. Identification of residues important for ligand binding to the human 5-hydroxytryptamine1A serotonin receptor.
      P K Chanda, M C Minchin, A R Davis, L Greenberg, Y Reilly, W H McGregor, R Bhat, M D Lubeck, S Mizutani and P P Hung
      Molecular Pharmacology April 1993, 43 (4) 516-520;

  3. Bhikhabhai, R

    1. Kinetics of different human immunodeficiency virus type 1 reverse transcriptases resistant to human immunodeficiency virus type 1-specific reverse transcriptase inhibitors.
      Z Debyser, K De Vreese, P P Knops-Gerrits, V Baekelandt, R Bhikhabhai, B Strandberg, R Pauwels, J Anné, J Desmyter and E De Clercq
      Molecular Pharmacology April 1993, 43 (4) 521-526;

  4. Bonin, H

    1. The human beta 3-adrenergic receptor is resistant to short term agonist-promoted desensitization.
      F Nantel, H Bonin, L J Emorine, V Zilberfarb, A D Strosberg, M Bouvier and S Marullo
      Molecular Pharmacology April 1993, 43 (4) 548-555;

  5. Bouvier, M

    1. The human beta 3-adrenergic receptor is resistant to short term agonist-promoted desensitization.
      F Nantel, H Bonin, L J Emorine, V Zilberfarb, A D Strosberg, M Bouvier and S Marullo
      Molecular Pharmacology April 1993, 43 (4) 548-555;

  6. Brüne, B

    1. Efflux of cyclic GMP from activated human platelets.
      X B Wu, B Brüne, F Von Appen and V Ullrich
      Molecular Pharmacology April 1993, 43 (4) 564-568;

  7. Burchell, B

    1. Human bilirubin UDP-glucuronosyltransferase catalyzes the glucuronidation of ethinylestradiol.
      T Ebner, R P Remmel and B Burchell
      Molecular Pharmacology April 1993, 43 (4) 649-654;

C

  1. Chaki, S

    1. New signaling mechanism of angiotensin II in neuroblastoma neuro-2A cells: activation of soluble guanylyl cyclase via nitric oxide synthesis.
      S Chaki and T Inagami
      Molecular Pharmacology April 1993, 43 (4) 603-608;

  2. Chanda, P K

    1. Identification of residues important for ligand binding to the human 5-hydroxytryptamine1A serotonin receptor.
      P K Chanda, M C Minchin, A R Davis, L Greenberg, Y Reilly, W H McGregor, R Bhat, M D Lubeck, S Mizutani and P P Hung
      Molecular Pharmacology April 1993, 43 (4) 516-520;

  3. Chu, E

    1. Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-gamma.
      E Chu, D M Koeller, P G Johnston, S Zinn and C J Allegra
      Molecular Pharmacology April 1993, 43 (4) 527-533;

D

  1. Davis, A R

    1. Identification of residues important for ligand binding to the human 5-hydroxytryptamine1A serotonin receptor.
      P K Chanda, M C Minchin, A R Davis, L Greenberg, Y Reilly, W H McGregor, R Bhat, M D Lubeck, S Mizutani and P P Hung
      Molecular Pharmacology April 1993, 43 (4) 516-520;

  2. Debyser, Z

    1. Kinetics of different human immunodeficiency virus type 1 reverse transcriptases resistant to human immunodeficiency virus type 1-specific reverse transcriptase inhibitors.
      Z Debyser, K De Vreese, P P Knops-Gerrits, V Baekelandt, R Bhikhabhai, B Strandberg, R Pauwels, J Anné, J Desmyter and E De Clercq
      Molecular Pharmacology April 1993, 43 (4) 521-526;

  3. De Clercq, E

    1. Kinetics of different human immunodeficiency virus type 1 reverse transcriptases resistant to human immunodeficiency virus type 1-specific reverse transcriptase inhibitors.
      Z Debyser, K De Vreese, P P Knops-Gerrits, V Baekelandt, R Bhikhabhai, B Strandberg, R Pauwels, J Anné, J Desmyter and E De Clercq
      Molecular Pharmacology April 1993, 43 (4) 521-526;

  4. Desmyter, J

    1. Kinetics of different human immunodeficiency virus type 1 reverse transcriptases resistant to human immunodeficiency virus type 1-specific reverse transcriptase inhibitors.
      Z Debyser, K De Vreese, P P Knops-Gerrits, V Baekelandt, R Bhikhabhai, B Strandberg, R Pauwels, J Anné, J Desmyter and E De Clercq
      Molecular Pharmacology April 1993, 43 (4) 521-526;

  5. De Vreese, K

    1. Kinetics of different human immunodeficiency virus type 1 reverse transcriptases resistant to human immunodeficiency virus type 1-specific reverse transcriptase inhibitors.
      Z Debyser, K De Vreese, P P Knops-Gerrits, V Baekelandt, R Bhikhabhai, B Strandberg, R Pauwels, J Anné, J Desmyter and E De Clercq
      Molecular Pharmacology April 1993, 43 (4) 521-526;

  6. Dissanayake, V U

    1. [3H]PD 140376: a novel and highly selective antagonist radioligand for the cholecystokininB/gastrin receptor in guinea pig cerebral cortex and gastric mucosa.
      J C Hunter, N Suman-Chauhan, K G Meecham, V U Dissanayake, D R Hill, M C Pritchard, C O Kneen, D C Horwell, J Hughes and G N Woodruff
      Molecular Pharmacology April 1993, 43 (4) 595-602;

  7. Dubreuil, D

    1. Identification of partial agonists with low intrinsic activity at the inositol-1,4,5-trisphosphate receptor.
      S T Safrany, R A Wilcox, C Liu, D Dubreuil, B V Potter and S R Nahorski
      Molecular Pharmacology April 1993, 43 (4) 499-503;

E

  1. Ebner, T

    1. Human bilirubin UDP-glucuronosyltransferase catalyzes the glucuronidation of ethinylestradiol.
      T Ebner, R P Remmel and B Burchell
      Molecular Pharmacology April 1993, 43 (4) 649-654;

  2. Emorine, L J

    1. The human beta 3-adrenergic receptor is resistant to short term agonist-promoted desensitization.
      F Nantel, H Bonin, L J Emorine, V Zilberfarb, A D Strosberg, M Bouvier and S Marullo
      Molecular Pharmacology April 1993, 43 (4) 548-555;

G

  1. Goldin, A L

    1. Site-directed mutagenesis of the putative pore region of the rat IIA sodium channel.
      K J Kontis and A L Goldin
      Molecular Pharmacology April 1993, 43 (4) 635-644;

  2. Greenberg, L

    1. Identification of residues important for ligand binding to the human 5-hydroxytryptamine1A serotonin receptor.
      P K Chanda, M C Minchin, A R Davis, L Greenberg, Y Reilly, W H McGregor, R Bhat, M D Lubeck, S Mizutani and P P Hung
      Molecular Pharmacology April 1993, 43 (4) 516-520;

H

  1. Han, X

    1. Microsomal hydroxylation of 2- and 4-fluoroestradiol to catechol metabolites and their conversion to methyl ethers: catechol estrogens as possible mediators of hormonal carcinogenesis.
      S P Ashburn, X Han and J G Liehr
      Molecular Pharmacology April 1993, 43 (4) 534-541;

  2. Hill, D R

    1. [3H]PD 140376: a novel and highly selective antagonist radioligand for the cholecystokininB/gastrin receptor in guinea pig cerebral cortex and gastric mucosa.
      J C Hunter, N Suman-Chauhan, K G Meecham, V U Dissanayake, D R Hill, M C Pritchard, C O Kneen, D C Horwell, J Hughes and G N Woodruff
      Molecular Pharmacology April 1993, 43 (4) 595-602;

  3. Horwell, D C

    1. [3H]PD 140376: a novel and highly selective antagonist radioligand for the cholecystokininB/gastrin receptor in guinea pig cerebral cortex and gastric mucosa.
      J C Hunter, N Suman-Chauhan, K G Meecham, V U Dissanayake, D R Hill, M C Pritchard, C O Kneen, D C Horwell, J Hughes and G N Woodruff
      Molecular Pharmacology April 1993, 43 (4) 595-602;

  4. Hughes, J

    1. [3H]PD 140376: a novel and highly selective antagonist radioligand for the cholecystokininB/gastrin receptor in guinea pig cerebral cortex and gastric mucosa.
      J C Hunter, N Suman-Chauhan, K G Meecham, V U Dissanayake, D R Hill, M C Pritchard, C O Kneen, D C Horwell, J Hughes and G N Woodruff
      Molecular Pharmacology April 1993, 43 (4) 595-602;

  5. Hung, P P

    1. Identification of residues important for ligand binding to the human 5-hydroxytryptamine1A serotonin receptor.
      P K Chanda, M C Minchin, A R Davis, L Greenberg, Y Reilly, W H McGregor, R Bhat, M D Lubeck, S Mizutani and P P Hung
      Molecular Pharmacology April 1993, 43 (4) 516-520;

  6. Hunter, J C

    1. [3H]PD 140376: a novel and highly selective antagonist radioligand for the cholecystokininB/gastrin receptor in guinea pig cerebral cortex and gastric mucosa.
      J C Hunter, N Suman-Chauhan, K G Meecham, V U Dissanayake, D R Hill, M C Pritchard, C O Kneen, D C Horwell, J Hughes and G N Woodruff
      Molecular Pharmacology April 1993, 43 (4) 595-602;

I

  1. Inagami, T

    1. New signaling mechanism of angiotensin II in neuroblastoma neuro-2A cells: activation of soluble guanylyl cyclase via nitric oxide synthesis.
      S Chaki and T Inagami
      Molecular Pharmacology April 1993, 43 (4) 603-608;

J

  1. Johnston, P G

    1. Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-gamma.
      E Chu, D M Koeller, P G Johnston, S Zinn and C J Allegra
      Molecular Pharmacology April 1993, 43 (4) 527-533;

K

  1. Kandel, M

    1. G protein-linked receptors labeled by [3H]histamine in guinea pig cerebral cortex. I. Pharmacological characterization [corrected]
      W G Sinkins, M Kandel, S I Kandel, W Schunack and J W Wells
      Molecular Pharmacology April 1993, 43 (4) 569-582;

  2. Kandel, S I

    1. G protein-linked receptors labeled by [3H]histamine in guinea pig cerebral cortex. I. Pharmacological characterization [corrected]
      W G Sinkins, M Kandel, S I Kandel, W Schunack and J W Wells
      Molecular Pharmacology April 1993, 43 (4) 569-582;

  3. Kneen, C O

    1. [3H]PD 140376: a novel and highly selective antagonist radioligand for the cholecystokininB/gastrin receptor in guinea pig cerebral cortex and gastric mucosa.
      J C Hunter, N Suman-Chauhan, K G Meecham, V U Dissanayake, D R Hill, M C Pritchard, C O Kneen, D C Horwell, J Hughes and G N Woodruff
      Molecular Pharmacology April 1993, 43 (4) 595-602;

  4. Knops-Gerrits, P P

    1. Kinetics of different human immunodeficiency virus type 1 reverse transcriptases resistant to human immunodeficiency virus type 1-specific reverse transcriptase inhibitors.
      Z Debyser, K De Vreese, P P Knops-Gerrits, V Baekelandt, R Bhikhabhai, B Strandberg, R Pauwels, J Anné, J Desmyter and E De Clercq
      Molecular Pharmacology April 1993, 43 (4) 521-526;

  5. Koeller, D M

    1. Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-gamma.
      E Chu, D M Koeller, P G Johnston, S Zinn and C J Allegra
      Molecular Pharmacology April 1993, 43 (4) 527-533;

  6. Kontis, K J

    1. Site-directed mutagenesis of the putative pore region of the rat IIA sodium channel.
      K J Kontis and A L Goldin
      Molecular Pharmacology April 1993, 43 (4) 635-644;

L

  1. Liehr, J G

    1. Microsomal hydroxylation of 2- and 4-fluoroestradiol to catechol metabolites and their conversion to methyl ethers: catechol estrogens as possible mediators of hormonal carcinogenesis.
      S P Ashburn, X Han and J G Liehr
      Molecular Pharmacology April 1993, 43 (4) 534-541;

  2. Liu, C

    1. Identification of partial agonists with low intrinsic activity at the inositol-1,4,5-trisphosphate receptor.
      S T Safrany, R A Wilcox, C Liu, D Dubreuil, B V Potter and S R Nahorski
      Molecular Pharmacology April 1993, 43 (4) 499-503;

  3. Lloyd, R V

    1. Reexamination of the microsomal transformation of N-hydroxynorcocaine to norcocaine nitroxide.
      R V Lloyd, L Shuster and R P Mason
      Molecular Pharmacology April 1993, 43 (4) 645-648;

  4. Lubeck, M D

    1. Identification of residues important for ligand binding to the human 5-hydroxytryptamine1A serotonin receptor.
      P K Chanda, M C Minchin, A R Davis, L Greenberg, Y Reilly, W H McGregor, R Bhat, M D Lubeck, S Mizutani and P P Hung
      Molecular Pharmacology April 1993, 43 (4) 516-520;

M

  1. Marullo, S

    1. The human beta 3-adrenergic receptor is resistant to short term agonist-promoted desensitization.
      F Nantel, H Bonin, L J Emorine, V Zilberfarb, A D Strosberg, M Bouvier and S Marullo
      Molecular Pharmacology April 1993, 43 (4) 548-555;

  2. Mason, R P

    1. Reexamination of the microsomal transformation of N-hydroxynorcocaine to norcocaine nitroxide.
      R V Lloyd, L Shuster and R P Mason
      Molecular Pharmacology April 1993, 43 (4) 645-648;

  3. McGregor, W H

    1. Identification of residues important for ligand binding to the human 5-hydroxytryptamine1A serotonin receptor.
      P K Chanda, M C Minchin, A R Davis, L Greenberg, Y Reilly, W H McGregor, R Bhat, M D Lubeck, S Mizutani and P P Hung
      Molecular Pharmacology April 1993, 43 (4) 516-520;

  4. Meecham, K G

    1. [3H]PD 140376: a novel and highly selective antagonist radioligand for the cholecystokininB/gastrin receptor in guinea pig cerebral cortex and gastric mucosa.
      J C Hunter, N Suman-Chauhan, K G Meecham, V U Dissanayake, D R Hill, M C Pritchard, C O Kneen, D C Horwell, J Hughes and G N Woodruff
      Molecular Pharmacology April 1993, 43 (4) 595-602;

  5. Miledi, R

    1. Characterization of bicuculline/baclofen-insensitive (rho-like) gamma-aminobutyric acid receptors expressed in Xenopus oocytes. II. Pharmacology of gamma-aminobutyric acidA and gamma-aminobutyric acidB receptor agonists and antagonists.
      R M Woodward, L Polenzani and R Miledi
      Molecular Pharmacology April 1993, 43 (4) 609-625;

  6. Minchin, M C

    1. Identification of residues important for ligand binding to the human 5-hydroxytryptamine1A serotonin receptor.
      P K Chanda, M C Minchin, A R Davis, L Greenberg, Y Reilly, W H McGregor, R Bhat, M D Lubeck, S Mizutani and P P Hung
      Molecular Pharmacology April 1993, 43 (4) 516-520;

  7. Mizutani, S

    1. Identification of residues important for ligand binding to the human 5-hydroxytryptamine1A serotonin receptor.
      P K Chanda, M C Minchin, A R Davis, L Greenberg, Y Reilly, W H McGregor, R Bhat, M D Lubeck, S Mizutani and P P Hung
      Molecular Pharmacology April 1993, 43 (4) 516-520;

N

  1. Nahorski, S R

    1. Identification of partial agonists with low intrinsic activity at the inositol-1,4,5-trisphosphate receptor.
      S T Safrany, R A Wilcox, C Liu, D Dubreuil, B V Potter and S R Nahorski
      Molecular Pharmacology April 1993, 43 (4) 499-503;

  2. Nantel, F

    1. The human beta 3-adrenergic receptor is resistant to short term agonist-promoted desensitization.
      F Nantel, H Bonin, L J Emorine, V Zilberfarb, A D Strosberg, M Bouvier and S Marullo
      Molecular Pharmacology April 1993, 43 (4) 548-555;

  3. Narahashi, T

    1. Immobilization of sodium channel gating charge in crayfish giant axons by the insecticide fenvalerate.
      V L Salgado and T Narahashi
      Molecular Pharmacology April 1993, 43 (4) 626-634;

P

  1. Pauwels, R

    1. Kinetics of different human immunodeficiency virus type 1 reverse transcriptases resistant to human immunodeficiency virus type 1-specific reverse transcriptase inhibitors.
      Z Debyser, K De Vreese, P P Knops-Gerrits, V Baekelandt, R Bhikhabhai, B Strandberg, R Pauwels, J Anné, J Desmyter and E De Clercq
      Molecular Pharmacology April 1993, 43 (4) 521-526;

  2. Polenzani, L

    1. Characterization of bicuculline/baclofen-insensitive (rho-like) gamma-aminobutyric acid receptors expressed in Xenopus oocytes. II. Pharmacology of gamma-aminobutyric acidA and gamma-aminobutyric acidB receptor agonists and antagonists.
      R M Woodward, L Polenzani and R Miledi
      Molecular Pharmacology April 1993, 43 (4) 609-625;

  3. Potter, B V

    1. Identification of partial agonists with low intrinsic activity at the inositol-1,4,5-trisphosphate receptor.
      S T Safrany, R A Wilcox, C Liu, D Dubreuil, B V Potter and S R Nahorski
      Molecular Pharmacology April 1993, 43 (4) 499-503;

  4. Pritchard, M C

    1. [3H]PD 140376: a novel and highly selective antagonist radioligand for the cholecystokininB/gastrin receptor in guinea pig cerebral cortex and gastric mucosa.
      J C Hunter, N Suman-Chauhan, K G Meecham, V U Dissanayake, D R Hill, M C Pritchard, C O Kneen, D C Horwell, J Hughes and G N Woodruff
      Molecular Pharmacology April 1993, 43 (4) 595-602;

Q

  1. Quattrochi, L C

    1. Nuclear uptake of the Ah (dioxin) receptor in response to omeprazole: transcriptional activation of the human CYP1A1 gene.
      L C Quattrochi and R H Tukey
      Molecular Pharmacology April 1993, 43 (4) 504-508;

R

  1. Regunathan, S

    1. Production and characterization of antibodies specific for the imidazoline receptor protein.
      H Wang, S Regunathan, D A Ruggiero and D J Reis
      Molecular Pharmacology April 1993, 43 (4) 509-515;

  2. Reilly, Y

    1. Identification of residues important for ligand binding to the human 5-hydroxytryptamine1A serotonin receptor.
      P K Chanda, M C Minchin, A R Davis, L Greenberg, Y Reilly, W H McGregor, R Bhat, M D Lubeck, S Mizutani and P P Hung
      Molecular Pharmacology April 1993, 43 (4) 516-520;

  3. Reis, D J

    1. Production and characterization of antibodies specific for the imidazoline receptor protein.
      H Wang, S Regunathan, D A Ruggiero and D J Reis
      Molecular Pharmacology April 1993, 43 (4) 509-515;

  4. Remmel, R P

    1. Human bilirubin UDP-glucuronosyltransferase catalyzes the glucuronidation of ethinylestradiol.
      T Ebner, R P Remmel and B Burchell
      Molecular Pharmacology April 1993, 43 (4) 649-654;

  5. Renton, K W

    1. Mechanism of hepatic cytochrome P450 modulation during Listeria monocytogenes infection in mice.
      S G Armstrong and K W Renton
      Molecular Pharmacology April 1993, 43 (4) 542-547;

  6. Ruggiero, D A

    1. Production and characterization of antibodies specific for the imidazoline receptor protein.
      H Wang, S Regunathan, D A Ruggiero and D J Reis
      Molecular Pharmacology April 1993, 43 (4) 509-515;

S

  1. Safrany, S T

    1. Identification of partial agonists with low intrinsic activity at the inositol-1,4,5-trisphosphate receptor.
      S T Safrany, R A Wilcox, C Liu, D Dubreuil, B V Potter and S R Nahorski
      Molecular Pharmacology April 1993, 43 (4) 499-503;

  2. Salgado, V L

    1. Immobilization of sodium channel gating charge in crayfish giant axons by the insecticide fenvalerate.
      V L Salgado and T Narahashi
      Molecular Pharmacology April 1993, 43 (4) 626-634;

  3. Schulz, R

    1. Coupling of prostaglandin E1 receptors to the stimulatory GTP-binding protein Gs is enhanced in neuroblastoma x glioma (NG108-15) hybrid cells chronically exposed to an opioid.
      H Ammer and R Schulz
      Molecular Pharmacology April 1993, 43 (4) 556-563;

  4. Schunack, W

    1. G protein-linked receptors labeled by [3H]histamine in guinea pig cerebral cortex. I. Pharmacological characterization [corrected]
      W G Sinkins, M Kandel, S I Kandel, W Schunack and J W Wells
      Molecular Pharmacology April 1993, 43 (4) 569-582;

  5. Shuster, L

    1. Reexamination of the microsomal transformation of N-hydroxynorcocaine to norcocaine nitroxide.
      R V Lloyd, L Shuster and R P Mason
      Molecular Pharmacology April 1993, 43 (4) 645-648;

  6. Sinkins, W G

    1. G protein-linked receptors labeled by [3H]histamine in guinea pig cerebral cortex. I. Pharmacological characterization [corrected]
      W G Sinkins, M Kandel, S I Kandel, W Schunack and J W Wells
      Molecular Pharmacology April 1993, 43 (4) 569-582;
    2. G protein-linked receptors labeled by [3H]histamine in guinea pig cerebral cortex. II. Mechanistic basis for multiple states of affinity [corrected]
      W G Sinkins and J W Wells
      Molecular Pharmacology April 1993, 43 (4) 583-594;

  7. Strandberg, B

    1. Kinetics of different human immunodeficiency virus type 1 reverse transcriptases resistant to human immunodeficiency virus type 1-specific reverse transcriptase inhibitors.
      Z Debyser, K De Vreese, P P Knops-Gerrits, V Baekelandt, R Bhikhabhai, B Strandberg, R Pauwels, J Anné, J Desmyter and E De Clercq
      Molecular Pharmacology April 1993, 43 (4) 521-526;

  8. Strosberg, A D

    1. The human beta 3-adrenergic receptor is resistant to short term agonist-promoted desensitization.
      F Nantel, H Bonin, L J Emorine, V Zilberfarb, A D Strosberg, M Bouvier and S Marullo
      Molecular Pharmacology April 1993, 43 (4) 548-555;

  9. Suman-Chauhan, N

    1. [3H]PD 140376: a novel and highly selective antagonist radioligand for the cholecystokininB/gastrin receptor in guinea pig cerebral cortex and gastric mucosa.
      J C Hunter, N Suman-Chauhan, K G Meecham, V U Dissanayake, D R Hill, M C Pritchard, C O Kneen, D C Horwell, J Hughes and G N Woodruff
      Molecular Pharmacology April 1993, 43 (4) 595-602;

T

  1. Tukey, R H

    1. Nuclear uptake of the Ah (dioxin) receptor in response to omeprazole: transcriptional activation of the human CYP1A1 gene.
      L C Quattrochi and R H Tukey
      Molecular Pharmacology April 1993, 43 (4) 504-508;

U

  1. Ullrich, V

    1. Efflux of cyclic GMP from activated human platelets.
      X B Wu, B Brüne, F Von Appen and V Ullrich
      Molecular Pharmacology April 1993, 43 (4) 564-568;

V

  1. Von Appen, F

    1. Efflux of cyclic GMP from activated human platelets.
      X B Wu, B Brüne, F Von Appen and V Ullrich
      Molecular Pharmacology April 1993, 43 (4) 564-568;

W

  1. Wang, H

    1. Production and characterization of antibodies specific for the imidazoline receptor protein.
      H Wang, S Regunathan, D A Ruggiero and D J Reis
      Molecular Pharmacology April 1993, 43 (4) 509-515;

  2. Wells, J W

    1. G protein-linked receptors labeled by [3H]histamine in guinea pig cerebral cortex. I. Pharmacological characterization [corrected]
      W G Sinkins, M Kandel, S I Kandel, W Schunack and J W Wells
      Molecular Pharmacology April 1993, 43 (4) 569-582;
    2. G protein-linked receptors labeled by [3H]histamine in guinea pig cerebral cortex. II. Mechanistic basis for multiple states of affinity [corrected]
      W G Sinkins and J W Wells
      Molecular Pharmacology April 1993, 43 (4) 583-594;

  3. Wilcox, R A

    1. Identification of partial agonists with low intrinsic activity at the inositol-1,4,5-trisphosphate receptor.
      S T Safrany, R A Wilcox, C Liu, D Dubreuil, B V Potter and S R Nahorski
      Molecular Pharmacology April 1993, 43 (4) 499-503;

  4. Woodruff, G N

    1. [3H]PD 140376: a novel and highly selective antagonist radioligand for the cholecystokininB/gastrin receptor in guinea pig cerebral cortex and gastric mucosa.
      J C Hunter, N Suman-Chauhan, K G Meecham, V U Dissanayake, D R Hill, M C Pritchard, C O Kneen, D C Horwell, J Hughes and G N Woodruff
      Molecular Pharmacology April 1993, 43 (4) 595-602;

  5. Woodward, R M

    1. Characterization of bicuculline/baclofen-insensitive (rho-like) gamma-aminobutyric acid receptors expressed in Xenopus oocytes. II. Pharmacology of gamma-aminobutyric acidA and gamma-aminobutyric acidB receptor agonists and antagonists.
      R M Woodward, L Polenzani and R Miledi
      Molecular Pharmacology April 1993, 43 (4) 609-625;

  6. Wu, X B

    1. Efflux of cyclic GMP from activated human platelets.
      X B Wu, B Brüne, F Von Appen and V Ullrich
      Molecular Pharmacology April 1993, 43 (4) 564-568;

Z

  1. Zilberfarb, V

    1. The human beta 3-adrenergic receptor is resistant to short term agonist-promoted desensitization.
      F Nantel, H Bonin, L J Emorine, V Zilberfarb, A D Strosberg, M Bouvier and S Marullo
      Molecular Pharmacology April 1993, 43 (4) 548-555;

  2. Zinn, S

    1. Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-gamma.
      E Chu, D M Koeller, P G Johnston, S Zinn and C J Allegra
      Molecular Pharmacology April 1993, 43 (4) 527-533;
Back to top

In this issue

Advertisement